Pfizer (PFE) Reports New Phase 1b Results of Gene Therapy in Ambulatory Boys with DMD Support Advancement into Pivotal Phase 3 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. IBM
5. META
6. SPY
7. ACN
8. NVDA
9. PRIM
10. PFE

Go back to Pfizer (PFE) Reports New Phase 1b Results of Gene Therapy in Ambulatory Boys with DMD Support Advancement into Pivotal Phase 3 Study
Pfizer Inc. (NYSE: PFE) Delayed: 25.00 -0.08 (0.32%)
Previous Close $25.08    52 Week High $37.39 
Open $24.99    52 Week Low $28.25 
Day High $25.24    P/E 15.15 
Day Low $24.78    EPS $1.65 
Volume 27,557,341